nodes	percent_of_prediction	percent_of_DWPC	metapath
Droxidopa—ADRB1—periodontitis	0.9	1	CbGaD
Droxidopa—Isoetarine—ADRB1—periodontitis	0.00192	0.195	CrCbGaD
Droxidopa—Aminosalicylic Acid—MPO—periodontitis	0.00178	0.181	CrCbGaD
Droxidopa—Mesalazine—MPO—periodontitis	0.0014	0.142	CrCbGaD
Droxidopa—Isoprenaline—ADRB1—periodontitis	0.000798	0.0811	CrCbGaD
Droxidopa—Norepinephrine—ADRB1—periodontitis	0.000739	0.0751	CrCbGaD
Droxidopa—Dopamine—ADRB1—periodontitis	0.000687	0.0698	CrCbGaD
Droxidopa—Epinephrine—ADRB1—periodontitis	0.00067	0.0682	CrCbGaD
Droxidopa—Aminosalicylic Acid—PTGS2—periodontitis	0.000669	0.068	CrCbGaD
Droxidopa—Epinephrine—TNF—periodontitis	0.000636	0.0647	CrCbGaD
Droxidopa—Mesalazine—PTGS2—periodontitis	0.000525	0.0534	CrCbGaD
Droxidopa—ADRA1B—Signaling by GPCR—CXCR2—periodontitis	6.64e-05	0.000737	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CXCL3—periodontitis	6.63e-05	0.000734	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—VIP—periodontitis	6.62e-05	0.000734	CbGpPWpGaD
Droxidopa—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	6.62e-05	0.000734	CbGpPWpGaD
Droxidopa—ADRA2C—G alpha (i) signalling events—CXCL8—periodontitis	6.58e-05	0.00073	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CXCL3—periodontitis	6.54e-05	0.000725	CbGpPWpGaD
Droxidopa—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	6.52e-05	0.000722	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—CXCR2—periodontitis	6.5e-05	0.00072	CbGpPWpGaD
Droxidopa—PAH—Disease—PTGS2—periodontitis	6.33e-05	0.000702	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—CCR2—periodontitis	6.25e-05	0.000692	CbGpPWpGaD
Droxidopa—SLC6A2—Transmembrane transport of small molecules—PPARA—periodontitis	6.24e-05	0.000692	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—CCR2—periodontitis	6.23e-05	0.00069	CbGpPWpGaD
Droxidopa—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	6.21e-05	0.000688	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—ADRB1—periodontitis	6.2e-05	0.000687	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—CCR2—periodontitis	6.19e-05	0.000686	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CXCL3—periodontitis	6.19e-05	0.000686	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—ADRB1—periodontitis	6.16e-05	0.000683	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—VIP—periodontitis	6.15e-05	0.000682	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—CCR2—periodontitis	6.11e-05	0.000677	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CXCL3—periodontitis	6.09e-05	0.000675	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—ADRB1—periodontitis	6.08e-05	0.000674	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—CXCR2—periodontitis	6.04e-05	0.000669	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR ligand binding—CCL2—periodontitis	5.98e-05	0.000663	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—MMP1—periodontitis	5.93e-05	0.000658	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—CXCR2—periodontitis	5.9e-05	0.000654	CbGpPWpGaD
Droxidopa—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	5.79e-05	0.000642	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—CCR2—periodontitis	5.78e-05	0.000641	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—ADRB1—periodontitis	5.76e-05	0.000638	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—ACP5—periodontitis	5.76e-05	0.000638	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—CCR2—periodontitis	5.69e-05	0.000631	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—CCR2—periodontitis	5.67e-05	0.000629	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—ADRB1—periodontitis	5.67e-05	0.000628	CbGpPWpGaD
Droxidopa—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	5.66e-05	0.000627	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—CCR2—periodontitis	5.65e-05	0.000626	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—ADRB1—periodontitis	5.62e-05	0.000623	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—CCR2—periodontitis	5.62e-05	0.000623	CbGpPWpGaD
Droxidopa—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	5.6e-05	0.000621	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—ADRB1—periodontitis	5.6e-05	0.00062	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—CCR2—periodontitis	5.55e-05	0.000615	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—MMP1—periodontitis	5.54e-05	0.000614	CbGpPWpGaD
Droxidopa—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	5.53e-05	0.000613	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—ADRB1—periodontitis	5.52e-05	0.000612	CbGpPWpGaD
Droxidopa—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—periodontitis	5.52e-05	0.000612	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—CXCR2—periodontitis	5.48e-05	0.000608	CbGpPWpGaD
Droxidopa—ADRB1—GPCR ligand binding—CCL2—periodontitis	5.45e-05	0.000604	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CXCL3—periodontitis	5.41e-05	0.0006	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR ligand binding—CCL2—periodontitis	5.4e-05	0.000598	CbGpPWpGaD
Droxidopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	5.38e-05	0.000596	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—NOS2—periodontitis	5.35e-05	0.000593	CbGpPWpGaD
Droxidopa—ADRA2A—G alpha (i) signalling events—CXCL8—periodontitis	5.35e-05	0.000593	CbGpPWpGaD
Droxidopa—ADRB2—GPCR ligand binding—CCL2—periodontitis	5.33e-05	0.000591	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—VIP—periodontitis	5.31e-05	0.000588	CbGpPWpGaD
Droxidopa—PAH—Metabolism—PTGS2—periodontitis	5.3e-05	0.000588	CbGpPWpGaD
Droxidopa—DDC—Metabolism—PPARA—periodontitis	5.27e-05	0.000585	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—CCR2—periodontitis	5.25e-05	0.000582	CbGpPWpGaD
Droxidopa—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	5.23e-05	0.00058	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—ADRB1—periodontitis	5.23e-05	0.000579	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—CCR2—periodontitis	5.17e-05	0.000573	CbGpPWpGaD
Droxidopa—ADRA2C—Platelet activation, signaling and aggregation—TGFB1—periodontitis	5.15e-05	0.000571	CbGpPWpGaD
Droxidopa—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	5.15e-05	0.000571	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—ADRB1—periodontitis	5.14e-05	0.00057	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—CCR2—periodontitis	5.05e-05	0.00056	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR ligand binding—CCL2—periodontitis	5.04e-05	0.000559	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—ADRB1—periodontitis	5.03e-05	0.000558	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CXCL3—periodontitis	5.03e-05	0.000557	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—NOS2—periodontitis	5e-05	0.000554	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR ligand binding—CCL2—periodontitis	4.96e-05	0.00055	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—VIP—periodontitis	4.83e-05	0.000536	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—VIP—periodontitis	4.79e-05	0.000531	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—VIP—periodontitis	4.73e-05	0.000524	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CXCR2—periodontitis	4.73e-05	0.000524	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR ligand binding—CXCL8—periodontitis	4.73e-05	0.000524	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—MMP3—periodontitis	4.72e-05	0.000523	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—CCL2—periodontitis	4.71e-05	0.000522	CbGpPWpGaD
Droxidopa—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	4.71e-05	0.000522	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—CCR2—periodontitis	4.7e-05	0.000521	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—ADRB1—periodontitis	4.68e-05	0.000518	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—ACP5—periodontitis	4.68e-05	0.000518	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—NTRK1—periodontitis	4.6e-05	0.00051	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—CCR2—periodontitis	4.59e-05	0.000509	CbGpPWpGaD
Droxidopa—PAH—Disease—TGFB1—periodontitis	4.58e-05	0.000507	CbGpPWpGaD
Droxidopa—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	4.58e-05	0.000507	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—ADRB1—periodontitis	4.57e-05	0.000507	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—MMP1—periodontitis	4.5e-05	0.000499	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—VIP—periodontitis	4.47e-05	0.000496	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR ligand binding—CCL2—periodontitis	4.41e-05	0.000489	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—VIP—periodontitis	4.4e-05	0.000488	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CXCR2—periodontitis	4.31e-05	0.000478	CbGpPWpGaD
Droxidopa—ADRB1—GPCR ligand binding—CXCL8—periodontitis	4.31e-05	0.000477	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—MMP3—periodontitis	4.3e-05	0.000477	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—MMP3—periodontitis	4.28e-05	0.000474	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CXCR2—periodontitis	4.27e-05	0.000473	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR ligand binding—CXCL8—periodontitis	4.27e-05	0.000473	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—CCR2—periodontitis	4.26e-05	0.000473	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—MMP3—periodontitis	4.26e-05	0.000472	CbGpPWpGaD
Droxidopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	4.25e-05	0.000471	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—ADRB1—periodontitis	4.25e-05	0.000471	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CXCR2—periodontitis	4.22e-05	0.000467	CbGpPWpGaD
Droxidopa—ADRB2—GPCR ligand binding—CXCL8—periodontitis	4.21e-05	0.000467	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—MMP3—periodontitis	4.21e-05	0.000466	CbGpPWpGaD
Droxidopa—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—periodontitis	4.19e-05	0.000464	CbGpPWpGaD
Droxidopa—ADRB3—GPCR downstream signaling—CXCL8—periodontitis	4.1e-05	0.000455	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR ligand binding—CCL2—periodontitis	4.09e-05	0.000454	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—NOS2—periodontitis	4.06e-05	0.00045	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CXCR2—periodontitis	3.99e-05	0.000442	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR ligand binding—CXCL8—periodontitis	3.99e-05	0.000442	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—MMP3—periodontitis	3.98e-05	0.000441	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CXCR2—periodontitis	3.93e-05	0.000435	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR ligand binding—CXCL8—periodontitis	3.92e-05	0.000435	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—MMP3—periodontitis	3.92e-05	0.000434	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—VIP—periodontitis	3.91e-05	0.000434	CbGpPWpGaD
Droxidopa—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	3.91e-05	0.000433	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—CXCL8—periodontitis	3.72e-05	0.000413	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CCR2—periodontitis	3.68e-05	0.000408	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—ADRB1—periodontitis	3.66e-05	0.000406	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—VIP—periodontitis	3.63e-05	0.000403	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CXCR2—periodontitis	3.49e-05	0.000386	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR ligand binding—CXCL8—periodontitis	3.48e-05	0.000386	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—MMP3—periodontitis	3.48e-05	0.000386	CbGpPWpGaD
Droxidopa—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	3.47e-05	0.000385	CbGpPWpGaD
Droxidopa—PAH—Disease—IL6—periodontitis	3.45e-05	0.000382	CbGpPWpGaD
Droxidopa—DDC—Metabolism—PTGS2—periodontitis	3.43e-05	0.00038	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CCR2—periodontitis	3.35e-05	0.000371	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CCR2—periodontitis	3.32e-05	0.000368	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—ADRB1—periodontitis	3.31e-05	0.000366	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CCR2—periodontitis	3.28e-05	0.000363	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—ADRB1—periodontitis	3.26e-05	0.000362	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CXCR2—periodontitis	3.24e-05	0.000359	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR ligand binding—CXCL8—periodontitis	3.24e-05	0.000359	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—MMP3—periodontitis	3.23e-05	0.000358	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—GGT1—periodontitis	3.2e-05	0.000355	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CCR2—periodontitis	3.1e-05	0.000344	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—ADRB1—periodontitis	3.09e-05	0.000342	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—CCL2—periodontitis	3.07e-05	0.00034	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CCR2—periodontitis	3.05e-05	0.000338	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—ADRB1—periodontitis	3.04e-05	0.000337	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—NTRK1—periodontitis	3e-05	0.000332	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—TGFB1—periodontitis	2.84e-05	0.000315	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—CCL2—periodontitis	2.8e-05	0.00031	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—MMP3—periodontitis	2.79e-05	0.000309	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—CCL2—periodontitis	2.78e-05	0.000308	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—CCL2—periodontitis	2.77e-05	0.000307	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—CCL2—periodontitis	2.73e-05	0.000303	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—NTRK1—periodontitis	2.73e-05	0.000303	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CCR2—periodontitis	2.71e-05	0.000301	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—NTRK1—periodontitis	2.71e-05	0.0003	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—ADRB1—periodontitis	2.7e-05	0.000299	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—NTRK1—periodontitis	2.67e-05	0.000296	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—CXCL8—periodontitis	2.67e-05	0.000296	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—TGFB1—periodontitis	2.66e-05	0.000295	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—GGT1—periodontitis	2.6e-05	0.000288	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—CCL2—periodontitis	2.59e-05	0.000287	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—CCL2—periodontitis	2.55e-05	0.000282	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—MMP3—periodontitis	2.54e-05	0.000282	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—NTRK1—periodontitis	2.53e-05	0.00028	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CCR2—periodontitis	2.52e-05	0.000279	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—MMP3—periodontitis	2.52e-05	0.000279	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—FGF2—periodontitis	2.51e-05	0.000279	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—ADRB1—periodontitis	2.51e-05	0.000278	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—NTRK1—periodontitis	2.49e-05	0.000276	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—MMP3—periodontitis	2.48e-05	0.000275	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—CXCL8—periodontitis	2.43e-05	0.00027	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—CXCL8—periodontitis	2.43e-05	0.000269	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—CXCL8—periodontitis	2.41e-05	0.000267	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—CXCL8—periodontitis	2.38e-05	0.000264	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—MMP3—periodontitis	2.35e-05	0.000261	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—MMP3—periodontitis	2.31e-05	0.000256	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—PPARA—periodontitis	2.29e-05	0.000254	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—CCL2—periodontitis	2.26e-05	0.000251	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—CXCL8—periodontitis	2.25e-05	0.00025	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—CXCL8—periodontitis	2.22e-05	0.000246	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—NTRK1—periodontitis	2.21e-05	0.000245	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—CXCL8—periodontitis	2.21e-05	0.000245	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—CXCL8—periodontitis	2.2e-05	0.000244	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—CXCL8—periodontitis	2.19e-05	0.000243	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—CXCL8—periodontitis	2.16e-05	0.00024	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—TGFB1—periodontitis	2.16e-05	0.000239	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—CCL2—periodontitis	2.1e-05	0.000233	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—IL6—periodontitis	2.09e-05	0.000232	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—MMP3—periodontitis	2.05e-05	0.000228	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—NTRK1—periodontitis	2.05e-05	0.000228	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—CXCL8—periodontitis	2.05e-05	0.000227	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—CXCL8—periodontitis	2.01e-05	0.000223	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—MMP9—periodontitis	1.99e-05	0.000221	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—CXCL8—periodontitis	1.97e-05	0.000218	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—MMP3—periodontitis	1.91e-05	0.000212	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PPARA—periodontitis	1.86e-05	0.000206	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—CXCL8—periodontitis	1.83e-05	0.000203	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CCL2—periodontitis	1.81e-05	0.000201	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—CXCL8—periodontitis	1.79e-05	0.000198	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—CXCL8—periodontitis	1.66e-05	0.000184	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CCL2—periodontitis	1.65e-05	0.000183	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—TGFB1—periodontitis	1.64e-05	0.000182	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—FGF2—periodontitis	1.64e-05	0.000182	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CCL2—periodontitis	1.64e-05	0.000181	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CCL2—periodontitis	1.62e-05	0.000179	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CCL2—periodontitis	1.53e-05	0.000169	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CCL2—periodontitis	1.5e-05	0.000167	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—FGF2—periodontitis	1.49e-05	0.000165	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—PTGS2—periodontitis	1.49e-05	0.000165	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—FGF2—periodontitis	1.48e-05	0.000164	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—FGF2—periodontitis	1.46e-05	0.000162	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CXCL8—periodontitis	1.43e-05	0.000159	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—FGF2—periodontitis	1.38e-05	0.000153	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—IL6—periodontitis	1.36e-05	0.000151	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—FGF2—periodontitis	1.36e-05	0.000151	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CCL2—periodontitis	1.34e-05	0.000148	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CXCL8—periodontitis	1.31e-05	0.000145	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—MMP9—periodontitis	1.3e-05	0.000144	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CXCL8—periodontitis	1.29e-05	0.000143	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CXCL8—periodontitis	1.28e-05	0.000142	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—IL6—periodontitis	1.24e-05	0.000138	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CCL2—periodontitis	1.24e-05	0.000138	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—IL6—periodontitis	1.24e-05	0.000137	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—IL6—periodontitis	1.23e-05	0.000136	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—IL6—periodontitis	1.21e-05	0.000135	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PTGS2—periodontitis	1.21e-05	0.000134	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CXCL8—periodontitis	1.21e-05	0.000134	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—FGF2—periodontitis	1.21e-05	0.000134	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CXCL8—periodontitis	1.19e-05	0.000132	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—MMP9—periodontitis	1.18e-05	0.000131	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—MMP9—periodontitis	1.17e-05	0.00013	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—MMP9—periodontitis	1.16e-05	0.000128	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—IL6—periodontitis	1.15e-05	0.000127	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—IL6—periodontitis	1.13e-05	0.000125	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—FGF2—periodontitis	1.12e-05	0.000124	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—MMP9—periodontitis	1.09e-05	0.000121	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—MMP9—periodontitis	1.08e-05	0.000119	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TGFB1—periodontitis	1.07e-05	0.000118	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CXCL8—periodontitis	1.06e-05	0.000117	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—IL6—periodontitis	1e-05	0.000111	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CXCL8—periodontitis	9.81e-06	0.000109	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TGFB1—periodontitis	9.73e-06	0.000108	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TGFB1—periodontitis	9.64e-06	0.000107	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—MMP9—periodontitis	9.55e-06	0.000106	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TGFB1—periodontitis	9.52e-06	0.000106	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—IL6—periodontitis	9.33e-06	0.000103	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TGFB1—periodontitis	9.01e-06	9.99e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—MMP9—periodontitis	8.88e-06	9.84e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TGFB1—periodontitis	8.87e-06	9.83e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IL6—periodontitis	8.05e-06	8.92e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TGFB1—periodontitis	7.87e-06	8.73e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IL6—periodontitis	7.33e-06	8.13e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TGFB1—periodontitis	7.32e-06	8.11e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IL6—periodontitis	7.27e-06	8.06e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IL6—periodontitis	7.17e-06	7.95e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IL6—periodontitis	6.79e-06	7.52e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IL6—periodontitis	6.68e-06	7.41e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IL6—periodontitis	5.93e-06	6.58e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IL6—periodontitis	5.51e-06	6.11e-05	CbGpPWpGaD
